ADUS
Addus HomeCare Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+30/100
Last price
113.16
▲ 0.18 (0.16%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
110.72
Prev close
112.98
Day high
114.66
Day low
112.24
Volume
125.55K
Market cap
$2.11B
P/E (TTM)
19.78
52W range
87.95 – 124.44
Day trading desk
Gap from prior close
-2.00%
Prior close 112.98
VWAP
113.12
+0.03% from price
Relative volume
0.38×
Quiet session
Session range
3.56%
110.72 – 114.66
Position in range
62%
Mid range
ATR (14D)
2.73
2.41% of price
Prior day high
113.80
PDH
Prior day low
110.24
PDL
Bid / ask spread
—
Quote not published
Session volume
83.12K
Avg 219.79K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.18%
-1.8%
1M
-4.72%
-5.9%
3M
+6.43%
+1.9%
6M
+21.48%
+3.3%
YTD
+5.37%
-8.9%
1Y
-1.48%
-17.9%
3Y
+32.83%
-49.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ADUS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+9.18K
Net buying
Buy transactions
7
10.14K shares
Sell transactions
4
966 shares
Net transactions
+11
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
514.59K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 22, 26 | DIXON HEATHER BRIANNE President |
SELL | 288 | $27.01K | Direct |
| Jun 10, 26 | RUSH JEAN Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | HILL MILBOURNE VERONICA Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | LOPEZ ESTEBAN Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | EARLEY MICHAEL M Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | FIRST MARK L Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | WEAVER SUSAN T. Director |
STOCK | 1.45K | $0 | Direct |
| Jun 10, 26 | GORDON DARIN J. Director |
STOCK | 1.45K | $0 | Direct |
| May 21, 26 | LOPEZ ESTEBAN Director |
SELL | 250 | $23.25K | Direct |
| May 19, 26 | LOPEZ ESTEBAN Director |
SELL | 250 | $23.25K | Direct |
| Apr 21, 26 | BLESSING CLIFF DONALD Officer |
SELL | 178 | $16.66K | Direct |
| Mar 2, 26 | RAINES MONICA Officer |
SELL | 224 | $22.88K | Direct |
| Feb 25, 26 | GAFFNEY SEAN Officer |
SELL | 1.26K | $133.97K | Direct |
| Feb 25, 26 | TUCKER DAVID W Officer |
SELL | 1.08K | $115.51K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ALLISON R DIRK |
Chief Executive Officer | 183.15K | Sale |
ANDERSON DARBY P |
Officer | 46.25K | Sale |
BICKHAM W BRADLEY |
President | 37.60K | Sale |
DIXON HEATHER BRIANNE |
President | 44.37K | Sale |
EARLEY MICHAEL M |
Director | 16.09K | Stock Award(Grant) |
FIRST MARK L |
Director | 15.07K | Stock Award(Grant) |
GAFFNEY SEAN |
Officer | 20.08K | Sale |
GORDON DARIN J. |
Director | 14.24K | Stock Award(Grant) |
POFF BRIAN |
Chief Financial Officer | 63.69K | Sale |
STEVENSON ROBERTSON JAMES |
Officer | 14.03K | Sale |
Fundamentals
Market cap$2.11B
Enterprise value$2.08B
Revenue (TTM)$1.48B
Gross profit$472.15M
EBITDA$160.54M
Net income$105.31M
EPS (TTM)$5.72
Free cash flow$116.25M
Total cash$99.57M
Total debt$108.82M
Book value / share$62.77
Shares outstanding18.67M
Float17.75M
Short % of float5.68%
Dividend yield0.00%
Beta (5Y)0.83
Valuation & profitability ratios
Trailing P/E19.78
Forward P/E15.01
PEG ratio0.99
Price / sales—
Price / book1.80
EV / revenue1.41
EV / EBITDA12.95
Gross margin31.98%
Operating margin9.68%
Profit margin7.13%
Return on equity9.71%
Return on assets6.27%
Debt / equity9.48
Current ratio1.69
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.42B | $1.15B | $1.06B | $951.12M | +23.2% |
| Operating revenue | $1.42B | $1.15B | $1.06B | $951.12M | +23.2% |
| Cost of revenue | $960.66M | $779.58M | $718.77M | $651.38M | +23.2% |
| Gross profit | $461.87M | $375.02M | $339.88M | $299.74M | +23.2% |
| Selling, general & admin | $306.85M | $258.80M | $234.79M | $216.94M | +18.6% |
| Total operating expense | $323.26M | $272.33M | $248.92M | $231.00M | +18.7% |
| Operating income | $138.62M | $102.69M | $90.96M | $68.74M | +35.0% |
| Net interest income | -$11.17M | -$3.34M | -$9.63M | -$8.57M | -234.6% |
| Pre-tax income | $127.44M | $99.35M | $81.33M | $60.17M | +28.3% |
| Tax provision | $31.54M | $25.75M | $18.81M | $14.15M | +22.4% |
| Net income | $95.91M | $73.60M | $62.52M | $46.02M | +30.3% |
| Net income to common | $95.91M | $73.60M | $62.52M | $46.02M | +30.3% |
| Basic EPS | 5.18 | 4.06 | 3.85 | 2.85 | +27.7% |
| Diluted EPS | 5.18 | 4.06 | 3.83 | 2.84 | +27.7% |
| EBIT | $141.06M | $107.08M | $92.43M | $69.08M | +31.7% |
| EBITDA | $157.47M | $120.61M | $106.56M | $83.14M | +30.6% |
| Basic shares | 18.52M | 18.15M | 16.23M | 16.13M | +2.0% |
| Diluted shares | 18.52M | 18.15M | 16.31M | 16.18M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $81.62M | $98.91M | $64.79M | $79.96M | -17.5% |
| Cash & short-term investments | $81.62M | $98.91M | $64.79M | $79.96M | -17.5% |
| Accounts receivable | $151.69M | $122.88M | $115.50M | $125.50M | +23.4% |
| Total current assets | $269.49M | $260.38M | $200.00M | $222.81M | +3.5% |
| Property, plant & equipment | $68.71M | $72.05M | $69.44M | $60.16M | -4.6% |
| Goodwill & intangibles | $1.10B | $1.08B | $754.98M | $655.02M | +1.8% |
| Total assets | $1.44B | $1.41B | $1.02B | $937.99M | +1.7% |
| Total current liabilities | $149.49M | $155.87M | $145.12M | $131.15M | -4.1% |
| Long-term debt | $120.96M | $218.44M | $124.13M | $131.77M | -44.6% |
| Total debt | $171.36M | $273.13M | $175.18M | $178.05M | -37.3% |
| Total liabilities | $352.00M | $442.14M | $317.73M | $304.45M | -20.4% |
| Retained earnings | $472.34M | $376.43M | $302.83M | $240.32M | +25.5% |
| Shareholder equity | $1.09B | $970.49M | $706.69M | $633.54M | +11.8% |
| Working capital | $120.00M | $104.51M | $54.89M | $91.66M | +14.8% |
| Net tangible assets | -$13.80M | -$109.71M | -$48.28M | -$21.48M | +87.4% |
| Shares issued | 18.52M | 18.15M | 16.23M | 16.13M | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $95.91M | $73.60M | $62.52M | $46.02M | +30.3% |
| Depreciation & amortisation | $16.41M | $13.53M | $14.13M | $14.06M | +21.3% |
| Stock-based compensation | $16.42M | $11.16M | $10.32M | $10.63M | +47.1% |
| Change in working capital | -$37.98M | $1.51M | $20.89M | $27.78M | -2,622.0% |
| Operating cash flow | $111.51M | $116.43M | $112.25M | $105.11M | -4.2% |
| Capital expenditure | -$7.72M | -$6.05M | -$9.45M | -$8.30M | -27.6% |
| Investing cash flow | -$32.50M | -$354.61M | -$119.24M | -$106.59M | +90.8% |
| Financing cash flow | -$96.30M | $272.30M | -$8.18M | -$87.45M | -135.4% |
| Free cash flow | $103.79M | $110.38M | $102.79M | $96.81M | -6.0% |
| End cash position | $81.62M | $98.91M | $64.79M | $79.96M | -17.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $377.42M | $363.61M | $373.08M | $362.30M | $349.44M | +3.8% |
| Operating revenue | $377.42M | $363.61M | $373.08M | $362.30M | $349.44M | +3.8% |
| Cost of revenue | $255.86M | $247.74M | $249.47M | $245.59M | $235.57M | +3.3% |
| Gross profit | $121.56M | $115.87M | $123.61M | $116.72M | $113.88M | +4.9% |
| Selling, general & admin | $78.49M | $77.77M | $77.18M | $79.37M | $77.08M | +0.9% |
| Total operating expense | $82.62M | $81.80M | $81.33M | $83.78M | $80.99M | +1.0% |
| Operating income | $38.94M | $34.07M | $42.28M | $32.94M | $32.89M | +14.3% |
| Net interest income | -$1.16M | -$1.64M | -$2.13M | -$2.58M | -$2.94M | +29.4% |
| Pre-tax income | $37.78M | $32.43M | $40.15M | $30.35M | $29.95M | +16.5% |
| Tax provision | $10.18M | $7.36M | $10.37M | $7.51M | $7.89M | +38.2% |
| Net income | $27.61M | $25.07M | $29.78M | $22.85M | $22.05M | +10.1% |
| Net income to common | $27.61M | $25.07M | $29.78M | $22.85M | $22.05M | +10.1% |
| Basic EPS | 1.48 | 1.34 | 1.61 | 1.24 | 1.20 | +10.1% |
| Diluted EPS | 1.48 | 1.34 | 1.61 | 1.24 | 1.20 | +10.1% |
| EBIT | $39.51M | $34.58M | $42.87M | $33.70M | $33.47M | +14.2% |
| EBITDA | $43.63M | $38.61M | $47.02M | $38.10M | $37.38M | +13.0% |
| Basic shares | 18.67M | 18.66M | 18.52M | 18.48M | 18.41M | +0.0% |
| Diluted shares | 18.67M | 18.66M | 18.52M | 18.48M | 18.41M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $99.57M | $103.06M | $81.62M | $101.92M | $91.18M | -3.4% |
| Cash & short-term investments | $99.57M | $103.06M | $81.62M | $101.92M | $91.18M | -3.4% |
| Accounts receivable | $145.12M | $144.82M | $151.69M | $134.05M | $140.10M | +0.2% |
| Total current assets | $284.15M | $272.88M | $269.49M | $260.66M | $263.05M | +4.1% |
| Property, plant & equipment | $64.89M | $65.66M | $68.71M | $69.32M | $70.41M | -1.2% |
| Goodwill & intangibles | $1.11B | $1.10B | $1.10B | $1.09B | $1.08B | +0.9% |
| Total assets | $1.46B | $1.44B | $1.44B | $1.42B | $1.41B | +1.4% |
| Total current liabilities | $168.15M | $149.47M | $149.49M | $156.80M | $151.38M | +12.5% |
| Long-term debt | $61.60M | $91.27M | $120.96M | $150.64M | $169.06M | -32.5% |
| Total debt | $108.82M | $138.74M | $171.36M | $202.49M | $222.25M | -21.6% |
| Total liabilities | $308.33M | $319.54M | $352.00M | $372.96M | $387.08M | -3.5% |
| Retained earnings | $525.02M | $497.41M | $472.34M | $442.56M | $419.71M | +5.6% |
| Shareholder equity | $1.15B | $1.12B | $1.09B | $1.05B | $1.02B | +2.9% |
| Working capital | $116.00M | $123.40M | $120.00M | $103.86M | $111.66M | -6.0% |
| Net tangible assets | $40.71M | $18.99M | -$13.80M | -$42.98M | -$53.63M | +114.3% |
| Shares issued | 18.67M | 18.66M | 18.52M | 18.48M | 18.41M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $27.61M | $25.07M | $29.78M | $22.85M | $22.05M | +10.1% |
| Depreciation & amortisation | $4.13M | $4.03M | $4.15M | $4.41M | $3.91M | +2.4% |
| Stock-based compensation | $4.39M | $5.00M | $4.55M | $4.29M | $4.42M | -12.2% |
| Change in working capital | $3.00M | $17.45M | -$37.77M | $18.83M | -$8.82M | -82.8% |
| Operating cash flow | $40.01M | $52.37M | $18.76M | $51.27M | $22.53M | -23.6% |
| Capital expenditure | -$1.34M | -$1.71M | -$2.66M | -$1.92M | -$1.25M | +21.7% |
| Investing cash flow | -$13.51M | -$1.69M | -$10.06M | -$22.76M | $1.70M | -698.2% |
| Financing cash flow | -$30.00M | -$29.23M | -$29.01M | -$17.76M | -$30.00M | -2.7% |
| Free cash flow | $38.67M | $50.65M | $16.10M | $49.35M | $21.28M | -23.7% |
| End cash position | $99.57M | $103.06M | $81.62M | $101.92M | $91.18M | -3.4% |
Options analytics
Put / call volume
0.06
Call-heavy session
Put / call open interest
0.11
Positioning, not flow
Max pain
75.00
-33.7% from spot
ATM implied vol
120.2%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
143
Contracts, this expiry
Put volume
9
Contracts, this expiry
Heaviest call OI
75.00
33 contracts
Heaviest put OI
90.00
11 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.70 | 1.73 | +1.9% |
| Mar 2026 | 1.54 | 1.62 | +4.9% |
| Dec 2025 | 1.72 | 1.77 | +2.6% |
| Sep 2025 | 1.53 | 1.56 | +1.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.79 | 13 | $388.69M | +7.3% |
| Next quarter | 1.89 | 13 | $393.84M | +5.6% |
| Current year | 7.05 | 14 | $1.52B | +7.1% |
| Next year | 7.51 | 14 | $1.60B | +4.9% |
Analyst targets & ownership
Mean target$133.69
High target$155.00
Low target$96.00
Implied upside18.14%
Analyst count13
ConsensusBUY
Strong buy / Buy3 / 8
Hold2
Sell / Strong sell0 / 1
Held by insiders2.81%
Held by institutions107.94%
Institutions holding410
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
112.67
+0.44% from price
SMA 20
114.90
-1.51% from price
SMA 50
116.73
-3.06% from price
SMA 100
108.06
+4.72% from price
SMA 200
105.64
+7.12% from price
EMA 12
113.30
-0.12% from price
EMA 26
114.59
-1.24% from price
EMA 50
114.01
-0.74% from price
RSI (14)
45.0
Neutral
MACD (12,26,9)
-1.29
Hist -0.28
ATR (14)
2.73
2.41% of price
Realised vol 30D
19.1%
Annualised
Bollinger upper
120.14
20, 2σ
Bollinger lower
109.66
20, 2σ
50 / 200 cross
Golden
116.73 vs 105.64
Trend bias
Above 200
+7.12%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.25
Less volatile than market
Correlation to SPY
0.11
Largely independent
Realised vol 30D
19.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.9%
Peak to trough
Max drawdown 5Y
-34.9%
Peak to trough
ATR 14
2.73
2.41% of price
Beta (reported)
0.83
5Y monthly, from filing
Short interest
Shares short
879.96K
Prior 1.01M
Change vs prior
-13.2%
Shorts covering
% of float
5.68%
Normal
% of shares out
4.71%
Against total outstanding
Days to cover
4.6
Liquid
Float
17.75M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 14, 26 | B of A Securities | DOWNGRADE | Buy | Neutral |
| Aug 5, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 9, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| May 18, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 15, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| May 6, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Mar 25, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Feb 25, 26 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| Feb 24, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Nov 13, 25 | BMO Capital | INITIATED | — | Market Perform |
| Nov 7, 25 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Nov 5, 25 | TD Cowen | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-14
Corporate Changes & Voting Matters
8-K · 2026-08-13
Periodic Financial Reports
10-Q · 2026-08-04
Corporate Changes & Voting Matters
8-K · 2026-08-03
Corporate Changes & Voting Matters
8-K · 2026-06-10
Periodic Financial Reports
10-Q · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-05-04
Proxy Statements
DEF 14A · 2026-04-23
Headlines
BTSG Deploys AI Across Operations: Will It Improve Margins?
Zacks · 7d ago
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
Zacks · 8d ago
2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
StockStory · 9d ago
Can Addus HomeCare (ADUS) Compound Wealth at Scale?
Insider Monkey · 14d ago
Addus HomeCare (ADUS) Heads To Jefferies, Is It Still 13% Undervalued?
Simply Wall St. · 20d ago
BofA Adjusts Price Target on Addus HomeCare to $125 From $140
MT Newswires · 21d ago
Addus HomeCare's Acquisition of AccentCare's Personal Care Business Likely to Support Growth, UBS Says
MT Newswires · 22d ago
Sector Update: Healthcare Stocks Gain Late Afternoon
MT Newswires · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.